Cargando…

Clinical complications of Mycoplasma pneumoniae disease--central nervous system.

The mechanism of the neurologic complications associated with primary atypical pneumonia is unknown. To examine the ability of Mycoplasma pneumoniae to enter the brain of experimental animals, the organism was inoculated into adult and suckling mice by various routes. After intranasal infection, M....

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, S., Kitamoto, O.
Formato: Texto
Lenguaje:English
Publicado: Yale Journal of Biology and Medicine 1983
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590568/
https://www.ncbi.nlm.nih.gov/pubmed/6433569
_version_ 1782161340764258304
author Ogata, S.
Kitamoto, O.
author_facet Ogata, S.
Kitamoto, O.
author_sort Ogata, S.
collection PubMed
description The mechanism of the neurologic complications associated with primary atypical pneumonia is unknown. To examine the ability of Mycoplasma pneumoniae to enter the brain of experimental animals, the organism was inoculated into adult and suckling mice by various routes. After intranasal infection, M. pneumoniae was isolated from brains and lungs of both groups of mice. After intracerebral inoculation, the high levels of the mycoplasma persisted for two months or more in the brains of suckling mice. In addition, after intravenous infection, the systemic spread of infection occurred in the mice treated with high doses of cyclophosphamide. Our results suggest that M. pneumoniae may be able to reach the brain via blood and it may occur with relative ease in compromised hosts.
format Text
id pubmed-2590568
institution National Center for Biotechnology Information
language English
publishDate 1983
publisher Yale Journal of Biology and Medicine
record_format MEDLINE/PubMed
spelling pubmed-25905682008-11-28 Clinical complications of Mycoplasma pneumoniae disease--central nervous system. Ogata, S. Kitamoto, O. Yale J Biol Med Research Article The mechanism of the neurologic complications associated with primary atypical pneumonia is unknown. To examine the ability of Mycoplasma pneumoniae to enter the brain of experimental animals, the organism was inoculated into adult and suckling mice by various routes. After intranasal infection, M. pneumoniae was isolated from brains and lungs of both groups of mice. After intracerebral inoculation, the high levels of the mycoplasma persisted for two months or more in the brains of suckling mice. In addition, after intravenous infection, the systemic spread of infection occurred in the mice treated with high doses of cyclophosphamide. Our results suggest that M. pneumoniae may be able to reach the brain via blood and it may occur with relative ease in compromised hosts. Yale Journal of Biology and Medicine 1983 /pmc/articles/PMC2590568/ /pubmed/6433569 Text en
spellingShingle Research Article
Ogata, S.
Kitamoto, O.
Clinical complications of Mycoplasma pneumoniae disease--central nervous system.
title Clinical complications of Mycoplasma pneumoniae disease--central nervous system.
title_full Clinical complications of Mycoplasma pneumoniae disease--central nervous system.
title_fullStr Clinical complications of Mycoplasma pneumoniae disease--central nervous system.
title_full_unstemmed Clinical complications of Mycoplasma pneumoniae disease--central nervous system.
title_short Clinical complications of Mycoplasma pneumoniae disease--central nervous system.
title_sort clinical complications of mycoplasma pneumoniae disease--central nervous system.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590568/
https://www.ncbi.nlm.nih.gov/pubmed/6433569
work_keys_str_mv AT ogatas clinicalcomplicationsofmycoplasmapneumoniaediseasecentralnervoussystem
AT kitamotoo clinicalcomplicationsofmycoplasmapneumoniaediseasecentralnervoussystem